Deutsche Bank AG bought a new stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 328,007 shares of the health services provider's stock, valued at approximately $17,634,000. Deutsche Bank AG owned approximately 0.62% of Maximus at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Dimensional Fund Advisors LP boosted its stake in shares of Maximus by 7.2% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,107,278 shares of the health services provider's stock worth $135,084,000 after acquiring an additional 141,362 shares in the last quarter. Reinhart Partners LLC. raised its stake in shares of Maximus by 131.8% in the 2nd quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider's stock valued at $106,575,000 after acquiring an additional 1,127,346 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Maximus by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 1,482,079 shares of the health services provider's stock worth $127,952,000 after purchasing an additional 5,130 shares during the last quarter. Van Berkom & Associates Inc. lifted its holdings in Maximus by 3.7% in the 1st quarter. Van Berkom & Associates Inc. now owns 1,172,190 shares of the health services provider's stock worth $75,137,000 after purchasing an additional 41,862 shares during the last quarter. Finally, Boston Partners boosted its position in Maximus by 47.0% during the third quarter. Boston Partners now owns 966,139 shares of the health services provider's stock worth $88,236,000 after purchasing an additional 308,892 shares during the period. Institutional investors and hedge funds own 97.21% of the company's stock.
Analyst Ratings Changes
Several brokerages have commented on MMS. Weiss Ratings reiterated a "hold (c-)" rating on shares of Maximus in a report on Monday, August 17th. Zacks Research cut shares of Maximus from a "hold" rating to a "strong sell" rating in a research note on Tuesday, August 11th. Finally, Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of "Reduce".
Read Our Latest Research Report on Maximus
Maximus Stock Performance
NYSE MMS opened at $58.29 on Friday. The company's fifty day moving average is $57.63 and its two-hundred day moving average is $64.60. Maximus, Inc. has a 52-week low of $52.73 and a 52-week high of $100.00. The company has a debt-to-equity ratio of 0.90, a current ratio of 2.42 and a quick ratio of 2.42. The firm has a market capitalization of $3.05 billion, a price-to-earnings ratio of 8.61 and a beta of 0.59.
Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The health services provider reported $2.22 EPS for the quarter, beating analysts' consensus estimates of $2.21 by $0.01. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The business had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same quarter in the prior year, the business earned $2.16 earnings per share. The firm's revenue for the quarter was down 5.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. Equities research analysts forecast that Maximus, Inc. will post 8.01 EPS for the current year.
Maximus Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Friday, August 14th will be given a $0.33 dividend. The ex-dividend date is Friday, August 14th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.3%. Maximus's dividend payout ratio (DPR) is currently 19.50%.
Maximus Profile
(
Free Report)
Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
